Hepatitis a virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon

Journal of Virology

Volumn 79, Issue 17, 2005, Pages 10968-10977

  Fensterl, Volker ^a   Grotheer, Dajana ^a   Berk, Iris ^a   Schlemminger, Stefanie ^a,b   Vallbracht, Angelika ^a   Dotzauer, Andreas ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETA INTERFERON; DOUBLE STRANDED RNA; I KAPPA B KINASE; I KAPPA B KINASE EPSILON; INTERFERON REGULATORY FACTOR 3; PHOSPHOTRANSFERASE; RETINOIC ACID INDUCIBLE GENE 1 PROTEIN; RNA BINDING PROTEIN; TBK1 PROTEIN; TIR DOMAIN CONTAINING ADAPTOR INDUCING INTERFERON BETA; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; HEPATITIS A VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; DEAD-BOX RNA HELICASES; DNA-BINDING PROTEINS; HEPATITIS A; HEPATITIS A VIRUS; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MEMBRANE GLYCOPROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RNA HELICASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

HEPATITIS A VIRUS;

EID: 23844435555     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.17.10968-10977.2005     Document Type: Article

References (59)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
2. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature 413:732-738.
3. Andrejeva, J., K. S. Childs, D. F. Young, T. S. Carlos, N. Stock, S. Goodbourn, and R. E. Randall. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc. Natl. Acad. Sci. USA 101:17264-17269.
4. Balachandran, S., E. Thomas, and G. N. Barber. 2004. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432:401-405.
5. Barro, M., and J. T. Patton. 2005. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. USA 102:4114-4119.
6. Brack, K., I. Berk, T. Magulski, J. Lederer, A. Dotzauer, and A. Vallbracht. 2002. Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA. J. Virol. 76:11920-11930.
7. Brack, K., W. Frings, A. Dotzauer, and A. Vallbracht. 1998. A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J. Virol. 72:3370-3376.
8. Breiman, A., N. Grandvaux, R. Lin, C. Ottone, S. Akira, M. Yoneyama, T. Fujita, J. Hiscott, and E. F. Meurs. 2005. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKε. J. Virol. 79:3969-3978.
9. Chariot, A., A. Leonardi, J. Müller, M. Bonif, K. Brown, and U. Siebenlist. 2002. Association of the adaptor TANK with the IκB kinase (IKK) regulator NEMO connects IKK complexes with IKKε and TBK1 kinases. J. Biol. Chem. 277:37029-37036.
10. Cohen, J. I., B. Rosenblum, J. T. Ticehurst, R. J. Daemer, S. M. Feinstone, and R. H. Purcell. 1987. Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc. Natl. Acad. Sci. USA 84:2497-2501.
11. Cui, X.-F., T. Imaizumi, H. Yoshida, E. C. Borden, and K. Satoh. 2004. Retinoic acid-inducible gene-I is induced by interferon-γ and regulates the expression of interferon-γ stimulated gene 15 in MCF-7 cells. Biochem. Cell Biol. 82:401-405.
12. Dotzauer, A., A. Vallbracht, and G. M. Keil. 1995. The proposed gene for VP1 of HAV encodes for a larger protein than that observed in HAV-infected cells and virions. Virology 213:671-675.
13. Dotzauer, A., S. M. Feinstone, and G. Kaplan. 1994. Susceptibility of non-primate cell lines to hepatitis A virus infection. J. Virol. 68:6064-6068.
14. Dotzauer, A., U. Gebhardt, K. Bieback, U. Göttke, A. Kracke, J. Mages, S. M. Lemon, and A. Vallbracht. 2000. Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J. Virol. 74:10950-10957.
15. Ehrhardt, C., C. Kardinal, W. J. Wurzer, T. Wolff, C. von Eichel-Streiber, S. Pleschka, O. Planz, and S. Ludwig. 2004. Rac1 and PAK1 are upstream of IKK-ε and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett. 567:230-238.
16. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S.-M. Liao, and T. Maniatis. 2003. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
17. Flehmig, B., H. Frank, G. G. Frösner, and H.-J. Gerth. 1977. Hepatitis A-virus particles in stools of patients from a natural hepatitis outbreak in Germany. Med. Microbiol. Immunol. 163:209-214.
18. Fleischer, B., S. Fleischer, K. Maier, K. H. Wiedmann, M. Sacher, H. Thaler, and A. Vallbracht. 1990. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 69:14-19.
19. Foy, E., K. Li, R. Sumpter, Jr., Y.-M. Loo, C. L. Johnson, C. Wang, P. M. Fish, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102:2986-2991.
20. Funami, K., M. Matsumoto, H. Oshiumi, T. Akazawa, A. Yamamoto, and T. Seya. 2004. The cytoplasmic 'linker region' in toll-like receptor 3 controls receptor localization and signaling. Int. Immunol. 16:1143-1154.
21. Gauss-Müller, V., and F. Deinhardt. 1984. Effect of hepatitis A virus infection on cell metabolism in vitro. Proc. Soc. Exp. Biol. Med. 175:10-15.
22. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 81:2341-2364.
23. Gust, I. D., and S. M. Feinstone. 1988. Hepatitis A. CRC Press, Inc., Boca Raton, Fla.
24. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda, and S. Akira. 2004. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641-1650.
25. Imaizumi, T., N. Yagihashi, M. Hatakeyama, K. Yamashita, A. Ishikawa, K. Taima, H. Yoshida, S. Yagihashi, and K. Satoh. 2004. Upregulation of retinoic acid-inducible gene-I in T24 urinary bladder carcinoma cells stimulated with interferon-γ. Tohoku J. Exp. Med. 203:313-318.
26. Kärber, G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 162:480-483.
27. Kucharczak, J., M. J. Simmons, Y. Fan, and C. Gélinas. 2003. To be, or not to be: NF-κB is the answer-role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22:8961-8982.
28. Kumar, K. P., K. M. McBride, B. K. Weaver, C. Dingwall, and N. C. Reich. 2000. Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol. Cell. Biol. 20:4159-4168.
29. Li, K., E. Foy, J. C. Ferreon, M. Nakamura, A. C. M. Ferreon, M. Ikeda, S. C. Ray, M. Gale, Jr., and S. M. Lemon. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102:2992-2997.
30. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
31. Maier, K., P. Gabriel, E. Koscielniak, Y.-D. Stierhof, K. H. Wiedmann, B. Flehmig, and A. Vallbracht. 1988. Hum. gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection. J. Virol. 62:3756-3763.
32. Maniatis, T., J. V. Falvo, T. H. Kim, T. K. Kim, C. H. Lin, B. S. Parekh, and M. G. Wathelet. 1998. Structure and function of the interferon-β enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63:609-620.
33. Matsumoto, M., S. Kikkawa, M. Kohase, K. Miyake, and T. Seya. 2002. Establishment of a monoclonal antibody against human toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293:1364-1369.
34. McWhirter, S. M., K. A. Fitzgerald, J. Rosains, D. C. Rowe, D. T. Golenbock, and T. Maniatis. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101:233-238.
35. Meylan, E., K. Burns, K. Hofmann, V. Blancheteau, F. Martinon, M. Kelliher, and J. Tschopp. 2004. RIP1 is an essential mediator of toll-like receptor 3-induced NF-κB activation. Nat. Immunol. 5:503-507.
36. Nishiya, T., and A. L. DeFranco. 2004. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the toll-like receptors. J. Biol. Chem. 279:19008-19017.
37. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003. TICAM-1, an adaptor molecule that participates in toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4:161-167.
38. Perry, A. K., E. K. Chow, J. B. Goodnough, W.-C. Yeh, and G. Cheng. 2004. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J. Exp. Med. 199:1651-1658.
39. Ronco, L. V., A. Y. Karpova, M. Vidal, and P. M. Howley. 1998. Hum. papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity, Genes Dev. 12:2061-2072.
40. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13:539-548.
41. Sato, S., M. Sugiyama, M. Yamamoto, Y. Watanabe, T. Kawai, K. Takeda, and S. Akira. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the toll-like receptor signaling. J. Immunol. 171:4304-4310.
42. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
43. Sharma, S., B. R. tenOever, N. Grandvaux, G.-P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151.
44. Stierhof, Y.-D. 1989. Ph.D. thesis. Eberhard-Karls-Universität, Tübingen, Germany.
45. Suhara, W., M. Yoneyama, T. Iwamura, S. Yoshiitmra, K. Tamura, H. Namiki, S. Aimoto, and T. Fujita. 2000. Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300. J. Biochem. 128:301-307.
46. Sumpter, Jr., R., Y.-M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
47. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100.
48. Tojima, Y., A. Fujimoto, M. Delhase, Y. Chen, S. Hatakeyama, K.-I. Nakayama, Y. Kaneko, Y. Nimura, N. Motoyama, K. Ikeda, M. Karin, and M. Nakanishi. 2000. NAK is an IκB kinase-activating kinase. Nature 404:778-782.
49. Vallbracht, A., and B. Flehmig. 1985. Elimination of a persistent hepatitis A infection in cell cultures by interferon, p. 339-345. In H. Kirchner and H. Schellekens (ed.), The biology of the interferon system 1984. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
50. Vallbracht, A., K. Maier, Y.-D. Stierhof, K. H. Wiedmann, B. Flehmig, and B. Fleischer. 1989. Liver-derived cytotoxic T cells in hepatitis A virus infection. J. Infect. Dis. 160:209-217.
51. Vallbracht, A., L. Hofman, K. G. Wurster, and B. Flehmig. 1984. Persistent infection of human fibroblasts by hepatitis A virus. J. Gen. Virol. 65:609-615.
52. Vallbracht, A., P. Gabriel, J. Zahn, and B. Flehmig. 1985. Hepatitis A virus infection and the interferon system. J. Infect. Dis. 152:211-213.
53. Wang, X., M. Li, H. Zheng, T. Muster, P. Palese, A. A. Beg, and A. García-Sastre. 2000. Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon. J. Virol. 74:11566-11573.
54. Weaver, B. K., O. Ando, K. P. Kumar, and N. C. Reich. 2001. Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J. 15:501-514.
55. Xiang, Y., R. C. Condit, S. Vijaysri, B. Jacobs, B. R. G. Williams, and R. H. Silverman. 2002. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 76:5251-5259.
56. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. A novel toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the toll-like receptor signaling. J. Immunol. 169:6668-6672.
57. Yang, H., G. Ma, C. H. Lin, M. Orr, M. G, Wathelet. 2004. Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-β gene promoter. Eur. J. Biochem. 271:3693-3703.
58. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
59. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1087-1095.